(Q93736414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4121460%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

title

Chlorambucil in steroid-dependent nephrotic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4121460%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

1 reference

1 reference

W E Grupe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4121460%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

publication date

1 April 1973

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4121460%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

9 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4121460%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4121460%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4121460%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

page(s)

598-606

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4121460%20AND%20SRC:MED&resulttype=core&format=json

Effect of nitrogen mustard on clinical course of glomerulonephritis

9 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

The nephrotic syndrome in children. I. Clinical response to nitrogen mustard therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Mechlorethamine therapy for systemic lupus nephropathy. Analysis and review of ten years experience and a clinical study of 211 cases including 81 patients treated with mechlorethamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Effect of 6-mercaptopurine adminstration on antibody production and clinical course in systemic lupus erythematosus. Report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

THIOGUANINE IN THE TREATMENT OF CERTAIN AUTOIMMUNE, IMMUNOLOGIC AND RELATED DISEASES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Cyclophosphamide in the treatment of idiopathic lipoid nephrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Immunosuppressive therapy of chronic renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Blood pressure in children as determined under office conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

The simple assessment of selectivity in heavy proteinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Long-term assessment of steroid therapy in childhood nephrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Clinicopathological study of nephrotic syndrome in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Cyclophosphamide Therapy in the Nephrotic Syndrome in Childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Clinical evaluation of CB 1348 in leukemias and lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Multiple late complications of therapy with cyclophosphamide, including ovarian destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Sterility and testicular atrophy related to cyclophosphamide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Cyclophosphamide therapy in prepubertal rats and subsequent reproductive performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

Lung changes and chemotherapeutic agents in childhood. Report of a case associated with cyclophosphamide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2873%2980584-0

10.1016/S0022-3476(73)80584-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4121460%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

1 reference